Department of Obstetrics and Gynecology/Developmental and Pathological medicine

Medicine & Life Sciences

1. Active Immunotherapy 16%
2. Adjuvant Chemotherapy 9%
3. Aminopeptidases 33%
4. Angiotensin II 17%
5. Angiotensins 14%
6. Biomarkers 10%
7. Carcinoma 100%
8. Carcinosarcoma 16%
9. Cisplatin 11%
10. Cyclooxygenase 2 Inhibitors 14%
11. Cystadenofibroma 22%
12. Cystectomy 13%
13. Cytoreduction Surgical Procedures 13%
14. Dengue 14%
15. Drug Therapy 21%
16. Electrocoagulation 15%
17. Endometrial Hyperplasia 16%
18. Endometrial Neoplasms 25%
19. Endometriosis 18%
20. Endometrium 9%
21. Epithelium 11%
22. Estrogens 10%
23. Etodolac 8%
24. Fertility 29%
25. Fibrosarcoma 14%
26. Gestational Trophoblastic Disease 17%
27. Glutamyl Aminopeptidase 14%
28. Glycolipids 9%
29. Glycosphingolipids 16%
30. Glypicans 18%
31. Group Psychotherapy 9%
32. Gynecologic Surgical Procedures 14%
33. Herbal Medicine 13%
34. Hyaluronic Acid 12%
35. Hydatidiform Mole 16%
36. Hydrogels 13%
37. Hysterectomy 16%
38. Incidence 9%
39. Infertility 12%
40. Kinesin 15%
41. Knockout Mice 11%
42. lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase 28%
43. Laparotomy 9%
44. leucyl-cystinyl aminopeptidase 16%
45. Ligation 10%
46. liposomal doxorubicin 17%
47. Liposomes 12%
48. Lower Extremity 9%
49. Luteoma 11%
50. Lymph Node Excision 24%
51. Lymphedema 14%
52. Medroxyprogesterone Acetate 15%
53. Menstruation 13%
54. MicroRNAs 20%
55. Mothers 16%
56. Mucinous Adenocarcinoma 15%
57. Neoplasm Metastasis 35%
58. Neoplasms 55%
59. Observational Studies 10%
60. Omentum 10%
61. Ovarian Epithelial Carcinoma 57%
62. Ovarian Neoplasms 63%
63. Ovarian Teratoma 17%
64. Ovary 45%
65. Ovulation 13%
66. Oxaliplatin 14%
67. Paclitaxel 27%
68. Paraplegia 14%
69. Peptide Hormones 14%
70. Peritoneum 11%
71. Plasminogen Activator Inhibitor 1 13%
72. Platinum 12%
73. Pre-Eclampsia 12%
74. Pregnancy 19%
75. Pregnancy Outcome 12%
76. Propensity Score 34%
77. Proteins 10%
78. Recurrence 32%
79. Residual Neoplasm 17%
80. Retreatment 15%
81. Sequence Analysis 11%
82. Skeletal Muscle 11%
83. Spectrin 16%
84. Spinal Canal 14%
85. Squamous Cell Carcinoma 10%
86. Steroids 9%
87. Subunit Vaccines 14%
88. Surgeons 8%
89. Survival 34%
90. Swine 9%
91. Teratoma 14%
92. Terminally Ill 16%
93. Therapeutic Uses 10%
94. Therapeutics 14%
95. Ubiquitin 12%
96. Uterine Cervical Neoplasms 22%
97. Uterine Neoplasms 15%
98. Vietnam 16%
99. Virilism 17%
100. XX Disorders of Sex Development 46 21%